These findings suggest that restoring normal miR-145 activity, or enhancing complementary mechanisms such as integrin β8–mediated inhibition of TGF-β/Smad signaling, could help protect microvascular integrity and slow DKD progression [85,86,87]. This evidence concerns the gene TGFB1 and diabetic kidney disease.